Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Basal Cell Carcinoma: early-phase trial registry
13 of 25 indexed Basal Cell Carcinoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #652 of 28,707 conditions by registered trial count.
25 US clinical trials · 13 currently recruiting · #652 of 28,707 conditions by registered trial count
Basal Cell Carcinoma: 25 US clinical trials tracked, 13 recruiting.
Basal Cell Carcinoma is the subject of 25 registered US clinical trials on ClinicalTrials.gov, 13 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 13 in Phase 1-2 (earlier-stage). The most active sponsor is Memorial Sloan Kettering Cancer Center, running 4 of these trials.
Enrollment posture brief
Registry condition basal-cell-carcinoma
OPEN 13 | RECR 52% | LATE 1 | EARLY 13 | RANK #652 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Amblyopia (52% recruiting · 25 trials)
Basal Cell Carcinoma lists 13 open slots (52% of 25 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Basal Cell Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Basal Cell Carcinoma is recruiting above its size-band peers.
13 of 25 indexed trials (52%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Basal Cell Carcinoma research.
Memorial Sloan Kettering Cancer Center accounts for 4 of 25 trials (16%). 21 distinct sponsors appear on at least one study for this condition label.
-
Most Basal Cell Carcinoma trials plan to enrol fewer than 100 people.
Median target enrolment is 45 among the 25 trials that report a genuine target (sentinel values excluded). 21 of those (84%) plan for fewer than 100 participants.
-
Basal Cell Carcinoma research is mostly interventional.
19 interventional and 6 observational studies make up this index (76% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
25 total, page 1 of 1
A Beta-only IL-2 ImmunoTherapY Study
Medicenna Therapeutics
NCT05086692
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies
Replimune
NCT04349436
To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
Stamford Pharmaceuticals
NCT06344052
Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas
Roswell Park Cancer Institute
NCT07182240
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NCT03521830
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Memorial Sloan Kettering Cancer Center
NCT05859074
Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy
University of Rochester
NCT06473103
Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma
Christopher Zachary
NCT04744935
Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma
University of California, San Diego
NCT06624475
Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy
Case Comprehensive Cancer Center
NCT05020912
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mayo Clinic
NCT07285044
Raman Spectroscopy and Skin Cancer
Renee Farrell
NCT06384924
CivaDerm(TM) Surface Therapy Pilot Study
CivaTech Oncology
NCT04480645
A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
NCT05294120
A Study of Observation and Follow-up in People With Basal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
NCT05473507
Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)
SkinJect
NCT04928222
DERM US and EU Validation Study
Skin Analytics Limited
NCT05126173
Electronic Brachytherapy for the Treatment of NMSC
Xoft
NCT01016899
Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology
Abramson Cancer Center at Penn Medicine
NCT01540695
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
Mayo Clinic
NCT00578214
Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)
The University of Texas Health Science Center, Houston
NCT00581425
Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins
Memorial Sloan Kettering Cancer Center
NCT01872130
Photochemical Tissue Bonding
Massachusetts General Hospital
NCT00586040
Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma
Sirnaomics
NCT04669808
Video-Based Treatment Options for Basal Cell Carcinoma
Emory University
NCT02158650
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 8 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Basal Cell Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Basal Cell Carcinoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Basal Cell Carcinoma page
25 registered trials, 13 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 13 Basal Cell Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Memorial Sloan Kettering Cancer Center sponsors the most Basal Cell Carcinoma trials on record, review their full trial history before evaluating a specific study. See Memorial Sloan Kettering Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Basal Cell Carcinoma condition card totals 25 registered trials; most-linked intervention Nivolumab; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.